LongeVC is a venture capital firm that invests in early-stage biotechnology and longevity companies, focusing on innovations that extend healthspan and address age-related diseases. Their strategy targets three main pillars: therapeutics, early-stage diagnostics and personalized care, and longevity infrastructure, prioritizing science-driven ventures with strong translational potential.
Portfolio
2
Fund Size
—
Top Stage
Unknown
Last 12 Mo
1
Stage Distribution
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Trogenix | Series A | $80M | Oct 2025 |
| Turn Biotechnologies | Unknown | — | Apr 2022 |
Top Co-Investors
Astellas Venture Management1 shared
IQ Capital1 shared
4BIO Capital1 shared
Cancer Research Horizons1 shared
Brain Tumor Investment Fund1 shared
Eli Lilly and Company1 shared
Calculus Capital1 shared
Last updated: 3 March 2026